Adverse side effects of dexamethasone in surgical patients

Polderman, J; Farhang-Razi, Violet; Dieren, Susan van; Kranke, Peter; DeVries, J. Hans; Hollmann, Markus W.; Preckel, Benedikt; Hermanides, Jeroen

doi:10.1002/14651858.cd011940

Cited by 69 publications

(41 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Consistent with the literature, we observed higher BG concentrations in the patients treated with corticosteroids. 30 None the less, the efficacy of liraglutide was comparable, whether patients received intraoperative corticosteroids or not.…”

Section: Discussionmentioning

confidence: 98%

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

Hulst

Visscher

Godfried

et al. 2019

Diabetes Obesity Metabolism

Self Cite

View full text Add to dashboard Cite

Aims Most cardiac surgery patients, with or without diabetes, develop perioperative hyperglycaemia, for which intravenous insulin is the only therapeutic option. This is labour‐intensive and carries a risk of hypoglycaemia. We hypothesized that preoperative administration of the glucagon‐like peptide‐1 receptor agonist liraglutide reduces the number of patients requiring insulin for glycaemic control during cardiac surgery. Materials and methods In this randomized, blinded, placebo‐controlled, parallel‐group, balanced (1:1), multicentre randomized, superiority trial, adult patients undergoing cardiac surgery in four Dutch tertiary hospitals were randomized to receive 0.6 mg subcutaneous liraglutide on the evening before surgery and 1.2 mg after induction of anaesthesia or matching placebo. Blood glucose was measured hourly and controlled using an insulin‐bolus algorithm. The primary outcome was insulin administration for blood glucose >8.0 mmol/L in the operating theatre. Research pharmacists used centralized, stratified, variable‐block, randomization software. Patients, care providers and study personnel were blinded to treatment allocation. Results Between June 2017 and August 2018, 278 patients were randomized to liraglutide (139) or placebo (139). All patients receiving at least one study drug injection were included in the intention‐to‐treat analyses (129 in the liraglutide group, 132 in the placebo group). In the liraglutide group, 55 (43%) patients required additional insulin compared with 80 (61%) in the placebo group and absolute difference 18% (95% confidence interval 5.9–30.0, P = 0.003). Dose and number of insulin injections and mean blood glucose were all significantly lower in the liraglutide group. We observed no difference in the incidence of hypoglycaemia, nausea and vomiting, mortality or postoperative complications. Conclusions Preoperative liraglutide, compared with placebo, reduces insulin requirements while improving perioperative glycaemic control during cardiac surgery.

show abstract

Section: Discussionmentioning

confidence: 98%

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

Hulst

Visscher

Godfried

et al. 2019

Diabetes Obesity Metabolism

Self Cite

View full text Add to dashboard Cite

show abstract

“…A recent meta-analysis of dexamethasone in surgical patients found no increase in the risk of postoperative infection (OR 1.01, 95% CI 0.80-1.27), but were unable to examine the effect on wound healing due to the imprecision in the available randomized trials. 13 Dexamethasone was found to have a mild increased in glucose in patients without diabetes for the first 12 hours after surgery (mean difference 13 mg/dL, 95% CI 6-21). Our institutional preference is to avoid dexamethasone in patients undergoing an electrophysiologic ablation procedure due to concern for inadequate scar formation at the ablation sites.…”

Section: Ta B L Ementioning

confidence: 94%

Incidence and predictors of postoperative nausea and vomiting in children undergoing electrophysiology ablation procedures

Lee

Banooni

Yuki

et al. 2020

Pediatric Anesthesia

View full text Add to dashboard Cite

Background Postoperative nausea and vomiting remains a significant concern for patients undergoing general anesthesia for percutaneous radiofrequency catheter ablation and cryoablation for tachyarrhythmias. Aim Our objective was to examine the incidence and risk factors for nausea and vomiting in the recovery room. Methods Children aged > 2 and ≤ 18 years who underwent general anesthesia for a percutaneous radiofrequency catheter ablation or cryoablation for a tachyarrhythmia between January 1, 2013, and January 1, 2016, were retrospectively reviewed. Outcomes included postoperative nausea, vomiting, and a composite of postoperative nausea and vomiting in the recovery room. Results We identified 611 patients with a mean age of 13.3 ± 3.9 years, 54.5% male, and a mean length of anesthesia was 3.9 ± 1.0 hours. Vomiting or retching in the postanesthesia care unit occurred in 7.4% of patients and nausea in an additional 12.4%. A composite of nausea and vomiting occurred in 95 patients (15.5%). On multivariable analysis, a subhypnotic propofol infusion (OR 0.45, 95% CI 0.23‐0.88, P = .019) and shorter anesthetic duration (OR 0.81 per 30 minutes, 95% CI 0.70‐0.94, P = .006) were independently associated with less vomiting in the recovery room. A history of PONV (OR 2.24, 95% CI 1.24‐4.05, P = .007) was independently associated with a composite of nausea and vomiting in the recovery room. Conclusions A shorter anesthetic time and a subhypnotic propofol infusion were predictive of a lower rate of postoperative vomiting in patients undergoing general anesthesia for electrophysiologic ablation procedures.

show abstract

“…The aim is to produce reviews that are open access and high quality, with transparent and rigorous methodology. The Anaesthesia Group's scope includes: pre‐operative assessment and preparation [1–4]; regional anaesthesia [5]; intra‐operative management [6–8]; and postoperative complications and care, including acute pain management [9,10]. There is also a separate Review Group dedicated to Emergency and Critical Care.…”

Section: Disseminationmentioning

confidence: 99%

The Cochrane Anaesthesia Review Group at 20: achievements and challenges in systematic reviews of evidence in peri‐operative care

et al. 2020

View full text Add to dashboard Cite

Adverse side effects of dexamethasone in surgical patients

Cited by 69 publications

References 23 publications

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

Incidence and predictors of postoperative nausea and vomiting in children undergoing electrophysiology ablation procedures

The Cochrane Anaesthesia Review Group at 20: achievements and challenges in systematic reviews of evidence in peri‐operative care

Contact Info

Product

Resources

About